Anti-NMDA-NR2A/B antibodies, in particular, cross-react with dsDNA and are correlated with neuropsychiatric, cognitive, behavioral, and mood abnormalities in SLE patients (Levite, 2014; Yang et al., 2017). This evidence concerns the gene GRIN2A and systemic lupus erythematosus.